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Abstract: Nervous necrosis virus (NNV), the causative agent of viral encephalopathy and retinopathy
(VER), is one of the most threatening viruses affecting marine and freshwater fish species worldwide.
Senegalese sole is a promising fish species in Mediterranean aquaculture but also highly susceptible to
NNV and VER outbreaks, that puts its farming at risk. The development of vaccines for aquaculture
is one of best tools to prevent viral spread and sudden outbreaks, and virus inactivation is the
simplest and most cost-effective method available. In this work, we have designed two inactivated
vaccines based on the use of formalin or binary ethylenimine (BEI) to inactivate a reassortant NNV
strain. After vaccination, the BEI-inactivated vaccine triggered the production of specific IgM-NNV
antibodies and stimulated innate and adaptive immune responses at transcriptional level (rtp3,
mx, mhcii and tcrb coding genes). Moreover, it partially improved survival after an NNV in vivo
challenge, reducing the mid-term viral load and avoiding the down-regulation of immune response
post-challenge. On the other hand, the formalin-inactivated vaccine improved the survival of fish
upon infection without inducing the production of IgM-NNV antibodies and only stimulating the
expression of herc4 and mhcii genes (in head-kidney and brain, respectively) during the vaccination
period; this suggests that other immune-related pathways may be involved in the partial protection
provoked. Although these vaccines against NNV showed encouraging results, further studies are
needed to improve sole protection and to fully understand the underlying immune mechanism.
Keywords: Senegalese sole; inactivated vaccine; BEI; formalin; nervous necrosis virus; immune
response; antibodies; gene expression
1. Introduction
Aquaculture is one of the fastest growing sectors of the food industry worldwide.
Nowadays, global aquaculture has surpassed marine catches in terms of fish protein
production for human consumption [1]. As a result of this growth, the spread of viruses has
also risen, due to the constant transport of eggs and larvae between fish farms all over the
world and because survivors of an epizootic outbreak often become asymptomatic carriers.
One of most widespread and dangerous viruses among fish farms is the nervous
necrosis virus (NNV; Genus Betanodavirus, Family Nodaviridae). NNV is the causative
agent of viral encephalopathy and retinopathy (VER), a neuropathological condition which
provokes mortality rates of up to 100%, particularly at early stages of development (larvae
and juveniles), especially in marine fish [2]. NNV is an icosahedral non-enveloped virus
composed of two positive sense single stranded RNA segments—RNA 1 coding for the
non-structural RNA-dependent RNA-polymerase, and RNA2 coding for the capsid protein.
NNV is grouped into four different genotypes: red-spotted grouper nervous necrosis
virus (RGNNV), barfin flounder nervous necrosis virus, tiger puffer nervous necrosis virus
and striped jack nervous necrosis virus (SJNNV) [2]. In addition, natural reassortants
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between RGNNV and SJNNV genotypes have been isolated as the causative agents of
disease outbreaks in different species, including sole (Solea sp.) and gilthead seabream
(Sparus aurata), the latter previously thought to be an asymptomatic NNV carrier [3–6].
To date, the most common preventive strategies regarding husbandry and NNV-free
broodstock selection appear to be inefficient at avoiding NNV outbreaks on fish farms due
to the stability of the virus in the aquatic environment [2]. Therefore, vaccination stands as
a cost-effective, innocuous and sustainable strategy to prevent NNV infections and severe
episodes. Different strategies have been followed to design NNV vaccines, including live
or inactivated viruses, DNA, virus-like particles, virus subunits, viral synthetic peptides or
recombinant protein using diverse administration methods [7–14]. Although the immune
response was triggered by most of them, they were only partially protective. As a first
approach to inactivated dead recombinant bacteria, a spinycterin system expressing a
downsized NNV coat protein was reported to induce 100% of sea bass (Dicentrarchus labrax)
survival upon NNV infection [15]. However, the existence of contradictory data and the
limited number of fish species on which vaccines have been tested make it difficult to
release an effective and wide-spectrum vaccine against NNV onto the market. In fact,
only two commercial formalin-inactivated vaccines against the RGNNV genotype, ALPHA
JECT micro® 1Noda (Pharmaq) and ICTHIOVAC® VNN (Hipra), are available for sea bass
vaccination in the Mediterranean area.
Senegalese sole (Solea senegalensis) is a highly promising flatfish species for aqua-
culture in Southern-European countries. However, one of the main drawbacks for its
intensive farming is its high susceptibility to reassortant RGNNV/SJNNV (referring to
the RNA1/RNA2 of the donors) strains [2]. In this work, a reassortant, sole pathogenic
NNV strain has been used to design two inactivated vaccine formulations (using either
formalin or binary ethylenimine, BEI). Juvenile sole individuals were intraperitoneally
vaccinated and the antibody response and expression profiles of immune-related genes
of vaccinated fish was assessed. In addition, fish survival upon NNV infection and the
immunostimulation of challenged sole was also analyzed.
2. Materials and Methods
2.1. Viruses and Cells
The strain used in this study, SpSs-IAusc160.03 (hereafter Ss160), a reassortant strain
exhibiting an RNA1 typed as RGNNV and an SJNNV-type RNA2, was isolated from Sene-
galese sole (Solea senegalensis) during an acute disease outbreak in a rearing facility in Spain
in 2003 [3]. E-11 cell line was cultured in L-15 Leibovitz (Lonza) medium supplemented
with 5% fetal bovine serum (FBS), penicillin (100 IU/mL) and streptomycin (100 mg/mL)
at 25 ◦C. For viral propagation, cells were inoculated at an MOI = 0.1 and incubated in L-15
with 2% FBS at 25 ◦C until the cytopathic effect (CPE) was extensive. The supernatant was
harvested and centrifuged to eliminate cell debris. Virus stock was titrated in 96-well plates
and expressed as the viral dilution infecting 50% of the cell cultures (TCID50), following a
previously defined methodology [16].
2.2. Vaccine Inactivation
Either formalin or binary ethylenimine (BEI) was used to inactivate Ss160 (iSs160; 108.5
TCID50/mL). Formalin inactivation was accomplished by adding the reagent into the viral
suspension to a final concentration of 0.2% during 7 or 9 days (d) at 25 ◦C in agitation. BEI
inactivation was achieved by mixing the virus with freshly prepared 0.1 M BEI dissolved in
0.175 M NaOH to a final concentration of 0.1, 1 or 4 mM. Inactivation was tested after 1, 24,
48 or 72 h of inactivation at 25 ◦C in agitation. After incubation, 1 M sodium thiosulphate
was added (1:10 in relation to BEI). Vaccines were confirmed to be completely inactivated
by the absence of CPE and viral titer in the E-11 cell line, after three 10-day blind passages,
as elsewhere [3]. In addition, in vivo toxicity was ruled out by intraperitoneal injection (ip)
in sole juveniles.
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2.3. Animals and Sampling Procedure
A total of 920 healthy Senegalese sole juveniles (2.9 ± 0.1 g body weight) from a
local farm were transferred to the Universidade de Santiago de Compostela (Spain) aquarium
facilities. Fish were randomly divided into 300 L running seawater tanks (33‰ salinity)
at 19 ◦C and with a 12 h light: 12 h dark photoperiod and acclimatized for 15 days prior
to the experiments. During acclimatization, fish were tested for the presence of NNV by
RT-qPCR (see below). Twenty fish were reserved to be mock-vaccinated and -infected until
the end of the trials.
Sampled fish were analyzed as follows: blood was collected from the caudal peduncles
and serum samples were obtained by centrifugation at 10,000× g for 10 min at 4 ◦C and
immediately stored at −20 ◦C until use. Afterwards fish were sacrificed with a tricaine
methanesulfonate overdose (MS-222, Sigma-Aldrich, St. Louis, MO, USA). Head-kidney
and brain were removed and immediately stored at −80 ◦C until later use for RT-qPCR
assays and cell culture when applicable.
2.4. Fish Vaccination
Senegalese sole specimens were randomly divided into ten 100 L tanks (n = 90/tank),
forming five experimental groups in duplicate. Fish were gently sedated with MS-222 and
intraperitoneally (ip) vaccinated as follows: Control group (Control) was injected with PBS
(100 µL/fish) while vaccinated groups received a single ip injection of Ss160 inactivated
with either formalin (form-iSs160) or BEI (BEI-iSs160) with high and low dose, 105 (iSs160L)
and 107 TCID50/mL (iSs160H), respectively. After vaccination, fish (n = 6 fish/group and
time point) were sampled at 7-, 15-, and 30-days post-vaccination (dpv) as described above.
2.5. NNV Challenge
Thirty days after vaccination, the remaining fish were challenged by immersion and
exposed to an Ss160 concentration of 105 TCID50/mL for 3 h with strong aeration (dissolved
oxygen concentration 11 ± 1 mg/L) at 22 ◦C. Control fish were mock-infected with L-15
medium. Mortalities and clinical signs were recorded daily. Viral load quantification in
brain tissue was performed on fish (n = 3 fish/group) sampled at 12-day intervals from the
initial detection of VER signs (see below). After 45 days of infection, serum, head-kidney
and brain samples from surviving fish (n = 6 fish/group) were analyzed.
2.6. Specific and Neutralizing Antibody Levels
The detection of specific antibodies against NNV (IgM-NNV) was performed by a pre-
viously described indirect ELISA with slight modifications [17]. Briefly, 20 µg of total pro-
teins from serum samples were diluted in coating buffer [100 mM Bicarbonate/Carbonate,
pH 9.6] and incubated overnight at 4 ◦C in 96 High Binding flat-bottomed plates (Sarsted,
Newton, NC, USA). After washing with PBST [PBS with 0.2% of Tween-20], the samples
were blocked with 5% skimmed milk in PBST for 1 h. Afterwards, incubation with a rabbit
anti-NNV (Abcam, Inc., Hong Kong; 1:10,000) was performed for 1 h at room temperature.
After three 5-min washes, the samples were incubated with the anti-rabbit IgG-HRP (Sigma
Aldrich; 1:25,000) for 1 h at room temperature. The reaction was revealed with 100 µL
per well of 3,3′,5,5′-tetramethylbenzidine single solution (ThermoFisher, Waltham, MA,
USA) for 20 min and stopped with 50 µL of 2 M sulphuric acid. The absorbance was read
at 450 nm with an iMark™ Microplate Absorbance Reader (BioRad, Heracles, CA, USA).
All assays were performed in duplicate. Previously assayed positive serum was used as a
positive control whilst the absence of sample, NNV, primary or secondary antibodies were
used as negative controls.
Neutralizing antibodies were assayed as elsewhere [14], with few modifications. In
brief, sera from fish obtained during vaccination and after 45 days post-challenge (dpc)
were decomplemented at 56 ◦C during 30 min. Serial dilutions (from 10 to 640-fold) of
decomplemented sera were incubated with equal volumes of 102.5 TCID50 mL of Ss160 for
1 h at 25 ◦C. After incubation, samples were assayed for NNV replication on E-11 cells as
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above, and serum dilution to provoke the absence of CPE was determined. A serum from
an infected fish served as a positive control.
2.7. Gene Expression by Real-Time Polymerase Chain Reaction
Total RNA was isolated from head-kidney and brain using an EZNA Total RNA
purification Kit (VWR) following the manufacturer’s instructions. The RNA samples were
resuspended in 70 µL of nuclease-free water (VWR), quantified by absorbance at 260 nm
in a Nanodrop ND-100 spectrophotometer (Nanodrop Technologies) and stored at −80
◦C. The first strand of cDNA was synthetized using Superscript IV (ThermoFisher) with
Random Hexameres (ThermoFisher) as previously described [18].
The expression of sole immune-related genes, namely the receptor transporter protein
(rtp3), E3 ubiquitin-protein ligase (herc4), interferon-induced GTP-binding protein Mx
(mx), major histocompatibility complex II (mhcii) and T-cell receptor beta (tcrb), were
analyzed by RT-qPCR, in an iCycler iQ CFX96TM Real Time System (BioRad) following
the manufacturer’s instructions using iQTM SYBR® Green Supermix (BioRad). Reaction
mixtures (containing 20 µL of SYBR Green supermix with 0.2 µM of the specific primers and
2 µL of cDNA template) were incubated for 3 min at 95 ◦C as an activation/denaturation
step, followed by 40 cycles of 15 s at 95 ◦C and 30 s at 55 (mhcii, mx and rtp3) or 58 ◦C
(tcrb and herc4). The specific primers used are shown in Table 1. Negative controls with
no template were always included in the reactions. The relative expression of all genes
was calculated by the 2−∆∆Ct method [19] using the beta actin (actb) coding gene as the
endogenous reference.
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Table 1. Primer sequences used for gene expression analysis.
Protein Name Gene Name Accession Number, UniGenName or Reference Sequence (5
′–3′)
Nodavirus RNA-dependent RNA polymerase RNA1 FJ803911 F TCCAAAAGAAAGAAGCATAC
R TGGCATGTACCACGGAAC
Senegalese sole Receptor transporter protein rtp3 [20] F GACGCCCCAATGGTGGAT
R CCAGATTCTTCATGAGGATGGTGAT




mx [20] F CCTCTCTCCTTCAGGATCCTCCTCCTGTGC
R CAAAACAAGAAACTATCTGCCTGGTGGTTC
Major histocompatibility complex II mhcii [20] F CGCTGATGAAAATGATCCACCTTCT
R ACCAGTCACATGACAGATCAGAGT
T-cell receptor beta chain tcrb solea_v4.1_unigene681812 * F CAGGAGGCACAGCTATGAAA
R TCTCCACCCAAATCTCCAAA
Beta actin actb DQ485686 F GACGACATGGAGAAGATC
R GGTGTTGAAGGTCTCAAA
* NOTE: UniGen transcriptomic database in http://www.scbi.uma.es/soleadb (accessed on 21 February 2021).
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2.8. Viral Quantification
Betanodavirus RNA1 extraction and amplification was accomplished as described
above using SnodR1 primers (Table 1). The corresponding standard curve was prepared
using 20-fold dilutions of a plasmid containing the full-length RNA1 of strain Ss160 in the
range of 101 to 107 copies/µL. Viral load data were calculated as RNA1 copies per g of fish
tissue. All samples were tested in triplicate.
2.9. Calculations and Statistics
All the data are shown as the mean ± standard error of the mean (SEM). The data
corresponding to the mRNA transcriptional levels was expressed as the relative gene
expression of the control or vaccinated group. IgM-NNV results are described as the optical
density (OD) at 450 nanometers. The relative percent survival (RPS) was calculated from
the cumulative mortality by the following formula:
RPS =
[(
1− % mortality o f vaccinated group





Variations between different time points and groups were analyzed by a two-way
ANOVA followed by Tukey’s post-hoc analysis. A non-parametric Kruskal-Wallis test,
followed by a multiple comparison test, was used when data did not meet parametric
assumptions. Survival rates were compared between groups using the Kaplan Meier test.
Letters denote statistical differences between groups at a same time-point (p < 0.05), whilst
asterisks indicate those differences between time-points in the same group (* p < 0.05;
** p < 0.01; **** p < 0.0001). All statistical analyses were conducted using GraphPad Prism 8.
3. Results
Prior to the vaccination assays, fish were tested by RT-qPCR and were confirmed to
be free of NNV (data not shown). In addition, five fish per vaccine formulation were ip
injected and monitored for 48 h before the beginning of the vaccination experiments to rule
out the toxicity of the inactivated vaccines. A control group with mock-vaccinated and
infected specimens was maintained until the end of the experiments as tank-effect control.
3.1. Formalin and BEI Effectively Inactivated Ss160
The effectivity of inactivation was tested using different chemical concentrations and
incubation times (Table 2). Complete formalin inactivation was achieved after nine days
of incubation since neither CPE nor viral titer were recorded after three blind passages
(Table 2). In the case of BEI, inactivation was accomplished with 1 mM after 72 or 4 mM
at any time point tested (Table 2). Based on these results, a form-iSs160 vaccine (0.2%
formalin for nine days) and a BEI-iSs160 vaccine (1 mM BEI for 72 h) were chosen for
in vivo vaccination assays. After 7, 15 and 30 dpv, NNV was not recovered in cell culture
from the brain of vaccinated sole (three brains individually, data not shown) corroborating
the complete inactivation of the vaccines chosen.
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Table 2. Safety test of form- and BEI-iSs160 vaccines after different concentration of chemical compounds treatments and incubation periods.
Chemical
Compound
Concentration Time CPE under Each Blind Passage Titer after Virus Inactivation(Log10
TCID50/mL)% mM Days Hours 1 2 3
Formalin 0.2
7 − − + nt
9 − − − <1.0
BEI
0.1
1 + nt nt nt
24 + nt nt nt
48 + nt nt nt
72 + nt nt nt
1
1 + + nt nt
24 + + nt nt
48 − − + nt
72 − − − <1.0
4
1 − − − <1.0
24 − − − <1.0
48 − − − <1.0
72 − − − <1.0
NOTE: −: negative; +: positive; nt: non-tested.
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3.2. BEI-iSs160 Vaccine Induces the Production of Specific NNV-IgM
After 7, 15 and 30 dpv, the production of specific antibodies against NNV was studied
(Figure 1). Only the BEI-iSs160 vaccine induced the synthesis of NNV-IgM from 7 dpv
onwards or after 30 dpv (iSs160H or iSs160L, respectively). Moreover, this increase was
significant with time in both BEI-iSs160 vaccinated groups, although no neutralizing
activity was observed (data not shown). On the contrary, form-iSs160 vaccines did not
provoke the production of specific antibodies at any time tested.
Figure 1. BEI-iSs160 vaccine induces specific humoral immunity. Specific anti-NNV IgM levels in the
serum of Senegalese sole specimens 7-, 15- and 30-days after intraperitoneal vaccination with low
and high dosages (105 and 107 TCID50/mL, iSs160L and iSs160H, respectively) of BEI-iSs160 vaccine
(inactivated with BEI) and form-iSs160 (formalin inactivated) or PBS (Control). Data represent the
mean ± standard error of the mean (SEM; n = 6 fish/group and time point). Lower letters denote
statistical differences between groups at a same time-point (p < 0.05), whilst asterisks indicate those
between time-points in the same group (* p < 0.05; **** p < 0.0001).
3.3. Immune-Related Gene Transcription in Vaccinated Fish
At the gene expression level, most of the studied immune-related markers were
modulated in the head-kidney of vaccinated fish, whilst in the brain they were barely
altered (Figures 2 and 3). Thus, in head-kidney, an overexpression of rpt3, mx and tcrb
genes was observed in the BEI-iSs160H group compared to the controls and the other
vaccinated groups after 7 dpv. However, a significant decrease down to control levels was
observed after 30 dpv in the transcription of the three genes (Figure 2A,C,E). Regarding the
fish vaccinated with form-iSs160, only the form-iSs160L triggered increased transcriptional
levels of herc4 at 30 dpv (Figure 2B). Finally, although mhcii gene expression was unaltered
in vaccinated groups compared to the controls, at 7 dpv in the BEI-iSs160H group, up-
regulated levels were observed when compared with formalin vaccinated fish (Figure 2D).
In brain tissue, only a few changes were seen at the short time point (7 dpv; Figure 3). Thus,
herc4 gene expression was increased in the BEI-iSs160H group whilst mhcii was increased
in the form-iSs160H and BEI-iSs160L groups (Figure 3D). In all cases, gene expression
returned to control levels after 30 dpv (Figure 3B,D).
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Figure 2. Vaccination produces the increment of immune response at transcriptional level in head-kidney. Expression of
immune-related genes (A) rtp3, (B) herc4, (C) mx, (D) mhcii and (E) tcrb in the head-kidney of Senegalese sole specimens
7-, 15- and 3-days after intraperitoneal vaccination with low and high dosages (105 and 107 TCID50/mL, iSs160L and
iSs160H, respectively) of BEI-iSs160 vaccine (inactivated with BEI) and form-iSs160 (formalin inactivated) or PBS (Control).
Data represent the mean ± standard error of the mean (SEM; n = 6 fish/group and time). Lower letters denote statistical
differences between groups at a same time-point (p < 0.05), whilst asterisks indicate those between time-points in the same
group (* p < 0.05; **** p < 0.0001).
Figure 3. Vaccination barely alters the immune response at transcriptional level in brain. Expression of immune-related
genes (A) rtp3, (B) herc4, (C) mx, (D) mhcii and (E) tcrb in the brain of Senegalese sole specimens 7-, 15- and 30-days after
intraperitoneal vaccination with low and high dosages (105 and107 TCID50/mL, iSs160L and iSs160H, respectively) of
BEI-iSs160 vaccine (inactivated with BEI) and form-iSs160 (formalin inactivated) or PBS (Control). Data represent the mean
± standard error of the mean (SEM; n = 6 fish/group and time). Lower letters denote statistical differences between groups
at a same time-point (p < 0.05), whilst asterisks indicate those between time-points in the same group (* p < 0.05; ** p < 0.01).
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3.4. BEI-iSs160 Vaccine Improves Survival and Reduces Viral Load in Sole Brain after Challenge
At 30 dpv, fish were bath-challenged with the Ss160 strain and at 12 dpc, control fish
started to show typical symptoms of VER disease such as erratic swimming or changes in skin
color (data not shown), whereas no external disease signs were observed in the vaccinated
fish. Therefore, from this time point and at 12-day intervals the viral load in the fish brain
tissue (n = 3 fish/group and time point) was individually assessed. From 12–24 dpc, in the
BEI-vaccinated groups the viral load was significantly lower (8.82× 104–1.98× 105 and 3.46×
104–7.99× 104 RNA copies per gram in the BEI-iSs160L and BEI-iSs160H groups, respectively)
than in the control fish (2.71 × 108 and 7.91 × 107 copies) (Figure 4A). However, at 36 dpc
viral RNA copies only remained low in the BEI-iSs160H group (3.3 × 106 versus 6.2 × 107
in the control) and at the end of the challenge (45 dpc) no significant differences were found
between vaccinated and control fish. No variations with the control group were observed in
both form-iSs160 vaccinated groups at the time-point assayed (Figure 4A).
After 45 dpc, a significant improvement of survival was observed with all vaccines
tested (Figure 4B), although the best results were obtained with the high concentrations.
Thus, whereas in the control group only 19.2% of the individuals survived, form- and
BEI-iSs160H groups displayed survival values of 54.38 and 60.42%, respectively (RPS 43.7
and 51.0). Low vaccine concentrations showed very similar RPS values (35.8 and 36.2, BEI-
and form-iSs160L, respectively).
Figure 4. All vaccines induce partial protection and BEI-iSs160 decreases the viral load after challenge. (A) viral load
(n = 3 fish/group and time) in brain and (B) Percent of survival during 45 days of in vivo infection in intraperitoneally
vaccinated Senegalese sole specimens vaccinated with low and high dosages (105 and 107 TCID50/mL, iSs160L and iSs160H,
respectively) of BEI-iSs160 vaccine (inactivated with BEI) and form-iSs160 (formalin inactivated) or PBS (Control). Infection
was performed by 3 h of immersion with 107 TCID50/mL. Survival rates were compared between groups using Kaplan
Meier test. Lower letters denote statistical differences between groups of the same time point according to the two-way
ANOVA test (p < 0.05).
3.5. NNV Infection Induces the Production of Specific NNV-IgM Similarly in All Fish
The level of specific NNV-IgM was analyzed 45 dpc (Figure 5). The in vivo infection
elicited the production of specific antibodies in vaccinated and control fish with no statistical
differences between groups. In addition, no NNV-neutralizing activity was recorded
(data not shown).
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Figure 5. Vaccination does not alter specific humoral immunity upon NNV infection. Specific anti-
NNV IgM levels in the serum of Senegalese sole specimens 45 days after 3 h of immersion with 105
TCID50/mL of Ss160 in previously intraperitoneally vaccinated Senegalese sole specimens vaccinated
with low and high dosages (105 and 107 TCID50/mL, iSs160L and iSs160H, respectively) of BEI-iSs160
vaccine (inactivated with BEI) and form-iSs160 (formalin inactivated) or PBS (Control). Infection was
performed by 3 h of immersion with 107 TCID50/mL. Data represent the mean ± standard error of
the mean (SEM; n = 6 fish/group and time). Statistical assay was performed by the two-way ANOVA
test (p < 0.05).
3.6. Immune-Related Genes in Head-Kidney after NNV Challenge
At 45 dpc, the analyzed genes were down-regulated in the head-kidney of all fish
treated with the formalin-inactivated vaccine. This down-regulation was also observed
in the BEI-iSs160L group, whereas it remained unaltered in the BEI-iSs160H vaccinated
fish (Figure 6A). In the brain, the mRNA transcriptomic levels of the studied immune-
related genes were unaltered in all vaccinated fish when compared with the control group
(Figure 6B). However, comparison among vaccinated groups showed that herc4 gene
expression was significantly higher in the BEI-iSs160H than in the BEI-iSs160L group
(Figure 6B).
Figure 6. Vaccination mainly decreases the immune response upon NNV infection at a transcriptional level in head-kidney
but not in brain. Expression of immune-related genes in (A) head-kidney and (B) brain of Senegalese sole specimens 45 days
after 3 h of immersion with 105 TCID50/mL of Ss160 in fish previously vaccinated with PBS (Control) or with low and
high dosages (105 and 107 TCID50/mL, iSs160L and iSs160H, respectively) of BEI-iSs160 vaccine (inactivated with BEI) and
form-iSs160 (formalin inactivated) or PBS (Control). Data represent the mean ± standard error of the mean (SEM; n = 6
fish/group and time). Lower letters denote statistical differences between groups according to the two-way ANOVA test
(p < 0.05).
4. Discussion
Although Senegalese sole is a promising species for Mediterranean aquaculture that
shows extraordinary susceptibility to NNV [18,21], there is only one study describing
an experimental recombinant NNV vaccine for this fish species which induced a good
antibody response but whose protective effect was not assessed [22]. Therefore, aiming to
prevent VER disease in sole, and considering that the simplicity of the production method
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makes the inactivated vaccines one of the most practical, we have designed a BEI- and a
formalin-inactivated vaccine using the sole-pathogenic reassortant strain, Ss160.
The main concept linked to the inactivation of viruses for vaccine production is to
generate totally safe vaccines, with the complete blockage of viral replication, without
damaging its antigenicity [23]. Our first observation was that the complete inactivation
of NNV was achieved with 0.2% formalin or 1 mM BEI after 9 days or 72 h of incuba-
tion, respectively. Previously, NNV has shown a certain resistance to be inactivated by
low concentrations of formalin (up to 0.16%), needing concentrations of at least 0.5% or
higher [24–27]. In the case of BEI, a previous concentration used to block NNV replication
was 4 mM [7,26,28,29]. Consumers today tend to be increasingly concerned about the
origin and the composition of the food they eat, so it may be worth reducing any chemical
compounds used in vaccination strategies, as done in this work, to avoid a generalized
rejection of the product but ensuring, at the same time, that NNV is completely inactivated
with no possibility of being spread into the wild.
Our post-vaccination results showed the abrupt induction of specific IgM-NNV pro-
duction in BEI-iSs160 vaccinated fish, in a concentration dependent manner, although they
were not neutralizing. Similarly, other BEI inactivated NNV vaccines for grouper strains
triggered the synthesis of IgM-NNV, but they also possessed neutralizing activity [28,29].
On the contrary, fish immunized with the form-iSs160 vaccine did not elicit an antibody
response. Most of the formalin inactivated vaccines against NNV reported in the literature
reveal a significant increment in neutralizing antibodies, regardless of whether the sera
are decomplemented or not [26,27,30–36]. However, formalin-inactivated vaccines appear
to be dose dependent, since dosages of around 107 TCID50/fish are necessary to provoke
an effective production of specific NNV antibodies in several fish species [27,31–36]. As a
matter of fact, the minimum vaccine concentration to successfully generate neutralizing
antibodies in groupers is 107 TCID50/fish [36]. Therefore, it is reasonable to assume that
the lack of antibody production observed in sole is due to the low vaccine concentration
used in this study (106 and 104 TCID50/fish).
To the best of our knowledge, this is the first study addressing the immune response
at a transcriptional level of sole immunized with NNV inactivated vaccines. Interestingly,
the transcription of rtp3, mx, herc4 and tcrb (all of them demonstrated to be up-regulated in
NNV-infected S. sole [20]) was considerably induced in the head-kidney of fish vaccinated
with the BEI-iSs160H, whereas in brain tissue it was barely altered. Thus, the gene expres-
sion of rtp3, a virus-responsive gene [37], was increased in the kidney soon after vaccination
(7 dpv) although the values were similar to the control fish at 30 dpv. This gene was also
greatly up-regulated in the head-kidney and brain of sole infected with the reassortant
Ss160 strain [20], just like in the brain and in several organs of NNV-infected Atlantic
salmon (Salmo salar) and Asian seabass (Lates calcarifer), respectively [37,38]. The rtp3 gene
shows an extraordinary sensitivity to NNV since its up-regulation is highly stimulated soon
after infection, appearing to be linked to the resistance to infection [38,39]. This information,
taken together with our results, points to Rtp3 as a relevant protein in the fight against
NNV. However, further studies are needed to clarify its specific function. In a similar
manner, the mx gene expression peaked after 7 dpv, perfectly simulating a natural NNV
infection. As a matter of fact, mx gene stimulation has usually been used as an indicator of
the vaccine’s antiviral effectiveness due to the significant induction of the type I interferon
(IFN) route—the most powerful antiviral pathway—in fish infected with NNV [20,40–44].
This induction seems to be regardless of the administration method, given that other tested
BEI-vaccines showed a suitable mx gene up-regulation during the vaccination period, when
administered either by bath or intraperitoneal injection [7,28]. Finally, the BEI-vaccine
seems to organize complete adaptive cellular immunity in head-kidney because tcrb (a
marker of cytotoxic T cells subsets) and mhcii (marker of T helper cells route activation
via antigen presenting cells) genes were up-regulated 7 days after vaccination, as seen
in groupers [7,28], concomitantly with the induction of specific IgM-NNV production
observed. It has previously been described how T cells were activated upon in vivo infec-
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tion with NNV [41,45–47] and even after vaccination with UV-inactivated, recombinant
or DNA vaccines [8,14,48], as with the BEI-iSs160H vaccine. Exceptionally, the herc4 gene
was the only gene up-regulated in the brain after BEI vaccination but not in head-kidney.
Although its function in fish is still unclear, the herc4 gene is up-regulated in the head-
kidney and brain of infected susceptible fish whilst inhibited in asymptomatic carriers of
NNV [20,49]. In addition, this molecule seems to be relevant in antiviral responses, as the
viral mimic poly (I:C) in macrophages induced an increment of its transcriptional levels [50].
Regarding the formalin-inactivated vaccines, only herc4 was overexpressed in the head-
kidney of fish injected with the form-iSs160L, whereas mhcii transcriptional levels were
increased in the brain of fish vaccinated with the form-iSs160H. Several formalin inacti-
vated vaccines have been reported to confer protection against NNV in different fish species
[26,27,31–34,51], but immune-related gene expression was only studied in European sea
bass [30]. In agreement with our results, mx was not significantly overexpressed in kidneys
although a significant increase was observed in the gut at 48 h post-vaccination [31].
Thirty days after vaccination, fish were bath-challenged. Although mortalities ap-
peared approximately at the same time as in most of the groups, only control fish showed
VER disease signs, such as erratic swimming and alterations in the skin color. The absence
of symptomatology coincided with the improvement in the survival of vaccinated fish,
especially those injected with BEI-iSs160H, which showed an RPS value of 51, whereas
survival of control fish was only 19.2%. Our results agree with those found in groupers of
different ages, where BEI-inactivated NNV triggered partial survival rates ranging between
52–67% in early juveniles when ip challenged [28]. However, no differences were shown in
the production of specific antibodies at the end of the challenge, contrary to what happens
in groupers immunized either with formalin- or BEI-inactivated vaccines [27,28,32,36].
In fact, in this fish species, a potent humoral response against NNV has been associated
with the improvement in the survival of vaccinated fish [32]. Our results indicate, therefore,
that cellular immunity can play an important role in the partial protection achieved in
sole, and that the form-iSs160 vaccine could induce additional defense mechanisms to
those analyzed in this study. Regarding survival rates provoked by formalin-inactivated
vaccines against NNV, there are many controversial results in which survival rates range
from 10.1–100% with an unclear common pattern [26,27,31,32,35,36]. Many variables may
be affecting the differential effectivity of this type of vaccine, such as the viral strain used,
the formalin dosage and inactivation period, the vaccine dosage or the virus load used in
the challenge. However, the vaccine dosage appears to be the most plausible explanation
as it is determinant for triggering neutralizing antibodies. Nevertheless, further studies
might be necessary to fully understand the conditioning factors for the effectivity of this
type of vaccine.
After the challenge, we observed a generalized down-regulation of all the genes
studied in the head-kidney of fish vaccinated with form-iSs160 (both concentrations).
However, the BEI-iSs160H was the only one maintaining transcriptional levels of immune-
related genes with no inhibition. This may be relevant given that NNV has been reported to
eradicate the innate immune response during the first moments of infection to freely spread
and colonize target tissues [40,52]. Finally, and despite the similarities in the survival rates
found in all groups, it is worth noting that BEI-iSs160H, in addition to maintaining the
transcriptional levels of immune-related genes, provoked a significant decrease in the viral
load in the brain tissue of challenged fish from 12–36 dpc, coinciding with the onset of
disease signs (day 12 post challenge) and the period of higher mortalities in control fish
(20–30 dpc).
5. Conclusions
NNV inactivated vaccines generated in this study conferred partial protection to
Senegalese sole when administered by ip injection, although they induced a different immune
response. On the one hand, BEI-iSs160 generates the innate (type I interferon pathway, rtp3)
and adaptive (specific IgM-NNV production, T cell markers) immune responses which last
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for at least 30 days. This vaccine improves sole survival upon NNV infection by decreasing
the viral load in brain tissue and maintaining their immune response unaltered until the
end of the challenge. The consistency of the results obtained with BEI inactivation ([28] and
this study) suggest that the reassortant strain Ss160 inactivated with BEI has the potential
to be used for developing vaccines which generate a robust immune response in S. sole.
However, further experimental approaches are needed to improve this promising vaccine,
including either booster immunizations or adjuvants. On the other hand, form-iSs160
decreases the mortality rates upon NNV infection even when a scarce immune stimulation
was observed, pointing to the fact that different immune-related pathways are involved.
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